Benjamin Pless is listed as an executive officer and director on 9 SEC Form D filings by 3 issuers between Mar 2009 and May 2015: NeuroPace Inc (Mountain View, CA — other health care — 2011–2013; $72M reported sold to 26 investors), Autonomic Technologies Inc (Redwood City, CA — other health care — 2009–2015; $48.2M reported sold to 23 investors) and Avertix Medical, Inc. (Eatontown, NJ — other health care — 2012–2014; $34.3M reported sold to 82 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $154.5M sold in total.
Listed alongside Frank Fischer (9 shared filings), David R. Fischell (6 shared filings), Andrew Taylor (4 shared filings), Dave Keenan (4 shared filings), Eric Fain (4 shared filings) and 30 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Benjamin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Benjamin Pless and found 12 differences, 1 worth asking the sponsor about: Benjamin Pless is no longer listed on the Jun 8, 2016 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.